Skip to main content
Suraj Estate Developers Limited logo

Suraj Estate Developers Limited — Investor Relations & Filings

Ticker · SURAJEST ISIN · INE843S01025 LEI · 33580025UQBQVKJRUR62 BSE.NS Real estate activities
Open in API
Filings indexed 284 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country IN India
Listing BSE.NS SURAJEST

About Suraj Estate Developers Limited

https://surajestate.com/

Suraj Estate Developers Limited specializes in the development of residential and commercial projects, with a strategic focus on the South-Central Mumbai region. Since its inception in 1986, the firm has established a significant presence in locales such as Dadar, Mahim, Matunga, and Prabhadevi. The company’s core operations involve the redevelopment of tenanted properties and the construction of high-rise residential buildings catering to value luxury and luxury segments. Additionally, it develops boutique commercial office spaces tailored for corporate clients. The firm is characterized by its expertise in navigating land-constrained urban environments and its track record of delivering specialized architectural projects within established residential hubs.

Recent filings

Filing Released Lang Actions
Suraj Estate Developers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Standalone ....
Regulatory Filings Classification · 80% confidence The document is an intimation to stock exchanges under SEBI’s Listing Regulations about a scheduled Board meeting to consider and approve audited financial results. It does not contain the actual financial results or management discussion, nor is it a shareholder meeting materials or proxy. It is a regulatory announcement required by listing rules, making it a general regulatory filing (RNS).
2026-05-18 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 85% confidence The document is an SEBI LODR regulation 32 compliance statement on deviation or variation in the utilization of funds raised under a preferential issue for the quarter ended March 31, 2026. It is a periodic regulatory filing disclosing fund‐utilization details, not an AGM pack, annual or interim report, nor a management presentation. It is not merely announcing the availability of a report but contains the full deviation statement itself. This falls under general regulatory/LODR compliance disclosures, i.e., Regulatory Filings (RNS).
2026-05-14 English
Monitoring Agency Report
Regulatory Filings Classification · 85% confidence The document is a periodic Monitoring Agency Report filed under SEBI Listing Obligations & Disclosure Requirements and SEBI Issue of Capital & Disclosure Requirements Regulations. It provides detailed compliance information on the utilization of proceeds of a Preferential Issue. It contains no standalone financial statements or management analysis of quarterly results (so it is not an IR or 10-K), nor is it an earnings release, dividend notice, investor presentation, or board change notice. It is a regulatory compliance submission that does not fit a more specific category, so it falls under the fallback “Regulatory Filings (RNS)”.
2026-05-14 English
Statement of Deviation or Variation in utilization of funds raised under Preferential Issue Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements Regulations 2015 for ....
Regulatory Filings Classification · 80% confidence The document is a formal compliance filing to the stock exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulation 32. It provides a "Statement of Deviation or Variation in utilization of funds raised" through a preferential issue for the quarter ended March 31, 2026. It is not announcing the initial fundraising or issuing a report publication notice but is a mandated regulatory submission showing fund usage. This does not fit into financial report categories (e.g., Annual Report, Interim Report) or financing event announcements (share issue) and instead is a routine regulatory filing required by listing regulations. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-14 English
Monitoring Agency Report for the Quarter ended March 31, 2026
Regulatory Filings Classification · 91% confidence The document is a Monitoring Agency Report filed under SEBI LODR regulations detailing the utilization of proceeds from a preferential issue, including quantitative tables and commentary by CARE Ratings. It is a mandatory compliance/regulatory filing rather than an earnings release, proxy statement, or capital raising announcement itself. It does not merely announce the report but includes the full monitoring report. This falls under general regulatory/compliance filings in our taxonomy.
2026-05-14 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-04-29 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.